Finance

Lists
Why is MSCL down 6.16%?
Dive Deeper
MSCL:TSE
Satellos Bioscience Inc
CA$10.05
-6.16%
(-0.66) 1D
Oct 13, 1:11:11 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MSCL...
Open
CA$10.70
High
CA$10.70
Low
CA$10.02
Mkt. cap
213.64M
Avg. vol.
11.53K
Volume
27.50K
52-wk high
CA$18.98
52-wk low
CA$7.56
EPS
-CA$2.83
Beta
1.15
Shares outstanding
21.22M
No. of employees
20
Open
CA$10.70
High
CA$10.70
Low
CA$10.02
Mkt. cap
213.64M
Avg. vol.
11.53K
Volume
27.50K
52-wk high
CA$18.98
52-wk low
CA$7.56
EPS
-CA$2.83
Beta
1.15
Shares outstanding
21.22M
No. of employees
20
News stories
From web sources and news partners
About Satellos Bioscience Inc
CEO-
Employees20
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitesatellos.com
Last report
Aug 13, 2026
Fiscal period
Q2 2026
-$0.56 / -$0.57
+2.18%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
3.99M
-11.46M
7.31M
9.64M
Cost of revenue
3.99M
-11.46M
7.31M
9.64M
Research and development expenses
-
16.92M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.97M
2.19M
2.73M
2.53M
Operating expense
1.97M
19.11M
2.73M
2.53M
Total operating expenses
5.97M
7.65M
10.04M
12.16M
Operating income
-5.97M
-7.65M
-10.04M
-12.16M
Other non operating income
-
-
-
-
EBT including unusual items
-5.80M
-7.24M
-9.74M
-11.67M
EBT excluding unusual items
-5.80M
-7.24M
-9.74M
-11.67M
Income tax expense
19.00K
58.00K
33.00K
44.00K
Effective tax rate
-0.33%
-0.80%
-0.34%
-0.38%
Other operating expenses
-
-
-
-
Net income
-5.82M
-7.30M
-9.77M
-11.72M
Net profit margin
-
-
-
-
Earnings per share
-
-0.50
-0.53
-0.56
Interest and investment income
349.00K
256.00K
421.00K
571.00K
Interest expense
-
-
-
-
Net interest expenses
349.00K
256.00K
421.00K
571.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.96M
-7.65M
-10.04M
-12.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps